Methotrexate embryopathy after exposure to low weekly doses in early pregnancy

Reproductive Toxicology

Volumn 43, Issue , 2014, Pages 26-29

  Martín, María Cecilia ^a   Barbero, Pablo ^a   Groisman, Boris ^a   Aguirre, Miguel Ángel ^a   Koren, Gideon ^b  

^a Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Aminopterin embryopathy; Methotrexate; Pregnancy; Rheumatoid arthritis

Indexed keywords

METHOTREXATE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG SAFETY; EMBRYOPATHY; FEMALE; HUMAN; OBSERVATIONAL STUDY; PREGNANCY OUTCOME; PRENATAL DRUG EXPOSURE; PROSPECTIVE STUDY; TERATOGENICITY;

ABNORMALITIES, MULTIPLE; ADOLESCENT; ADULT; ANTIRHEUMATIC AGENTS; CRANIOFACIAL ABNORMALITIES; FEMALE; FETAL DISEASES; HUMANS; MATERNAL-FETAL EXCHANGE; METHOTREXATE; PREGNANCY; RHEUMATIC DISEASES; YOUNG ADULT;

EID: 84888097693     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2013.10.005     Document Type: Article

References (8)

1. Hyoun S.C., Običan S.G., Scialli A.R. Teratogen update: methotrexate. Birth Defects Res A Clin Mol Teratol 2012, 94(4):187-207.
2. Cetin M.T., Arisoy A.H., Tap O., Kaya M., Urünsak I. Effects of methotrexate on the tubal morphology of rabbits: evaluation by electron microscopy. Gynecol Obstet Invest 2008, 65(4):217-221.
3. Wilson J.G. Use of rhesus monkeys in teratological studies. Fed Proc 1971, 30(January-February (1)):104-109.
4. Briggs G.G., Freeman R.K., Yaffe S.J. Drugs in pregnancy and lactation 2011, 927-932. 7th ed.
5. Nurmohamed L., Moretti M.E., Schechter T., Einarson A., Johnson D., Lavigne S.V., et al. Outcome following high-dose methotrexate in pregnancies misdiagnosed as ectopic. Am J Obstet Gynecol 2011, 205(December (6)):533.e1-533.e3.
6. Feldkamp M., Carey J.C. Clinical teratology counseling and consultation case report: low dose methotrexate exposure in the early weeks of pregnancy. Teratology 1993, 47:533-539.
7. [accessed 02.10.13]. https://drks-neu.uniklinik-freiburg.de/drks.../PdfDownstreamServlet.
8. Stamp L.K., Barclay M.L., O'Donnell J.L., Zhang M., Drake J., Frampton C., et al. Effects of changing from oral to subcutaneous methotrexate on red blood cell methotrexate polyglutamate concentrations and disease activity in patients with rheumatoid arthritis. J Rheumatol 2011, 38:2540-2547.